Iodine mediated mechanisms and thyroid carcinoma
- 6 October 2009
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 46 (5-6) , 302-318
- https://doi.org/10.3109/10408360903306384
Abstract
Iodine is a key element in the synthesis of thyroid hormones and the process of iodine transport by thyroid cells is active. Iodine deficiency, which is a known risk factor for thyroid cancer, may result from inadequate dietary iodine or from defects in iodine transportation. In contrast, a sufficient supply of iodine can induce cell-cycle arrest and apoptosis in thyroid cancer cells and may prevent the transformation of a differentiated thyroid cancer into a less differentiated or anaplastic form. However, the functions of iodine are complex, and the mechanisms of its action in thyroid cancer are unclear. This review focuses on the role of iodine in the carcinogenesis, proliferation, and apoptosis of thyroid cancers as well as on iodine transporters, most of which are impaired in thyroid cancer. Elucidating the roles of iodine may generate novel diagnostic and therapeutic approaches to thyroid cancer and improve current strategies for its treatment and prevention.Keywords
This publication has 206 references indexed in Scilit:
- International patterns and trends in thyroid cancer incidence, 1973–2002Cancer Causes & Control, 2008
- Pendred syndrome and iodide transport in the thyroidTrends in Endocrinology & Metabolism, 2008
- Risk factors for thyroid cancer: an epidemiological review focused on nutritional factorsCancer Causes & Control, 2008
- Induction of sodium iodide symporter gene and molecular characterisation of HNF3β/FoxA2, TTF-1 and C/EBPβ in thyroid carcinoma cellsBritish Journal of Cancer, 2008
- Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid NeoplasiaEndocrinology and Metabolism Clinics of North America, 2008
- Iodide accumulation provides kelp with an inorganic antioxidant impacting atmospheric chemistryProceedings of the National Academy of Sciences, 2008
- BRAFV600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomasBritish Journal of Cancer, 2007
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003
- Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)Nature Genetics, 1997